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Ocular toxoplasmosis is a potentially blinding intraocular inflammation. The intent of this study was to
investigate the role of Fas-FasL interaction in a murine model of acquired ocular toxoplasmosis induced by
intracameral inoculation of Toxoplasma gondii. Intraocular inflammation, Fas and FasL expression on lympho-
cytes and on ocular tissues, the occurrence of apoptosis, and the frequency of CD81 and CD41 T cells in the
infected eyes were analyzed in C57BL/6 (B6) mice. Susceptibility to parasite-induced intraocular inflammation
was observed in Fas-deficient (B6-lpr) and FasL-deficient (B6-gld) mice. Inoculation of 5,000 T. gondii tachy-
zoites induced significant intraocular inflammation associated with increase of Fas and FasL expression in the
inoculated eyes of wild-type B6 mice. Flow cytometry demonstrated a significant increase of Fas and FasL
expression on the splenocytes from naive mice incubated in vitro with the parasite and on the splenocytes har-
vested from the infected mice at day 8 after parasite inoculation. Apoptosis of inflammatory cells and cells in
ocular tissues was seen, and a greater frequency of CD81 than CD41 T cells was observed in the infected eyes.
The intensity of intraocular inflammation was greater in B6-lpr and B6-gld mice than in wild-type B6 mice (P <
0.05). The results suggest that Fas-FasL interaction associated with apoptosis is involved in the pathogenesis
of acquired ocular toxoplasmosis in mice.
Human infection with Toxoplasma gondii, an intracellular
parasite, is ubiquitous (18). Although benign in most individ-
uals, infection with T. gondii causes significant disease in two
groups, newborns and the immunosuppressed, in particular
those with AIDS. The parasite is also a frequent cause of po-
tentially blinding ocular disease (27, 31). Ocular toxoplasmosis
causes a necrotizing retinitis or retinochoroiditis (1, 11, 15),
which is reportedly immune mediated (28). Although most
cases of human eye infection are believed to be congenital in
origin, acquired acute toxoplasmic retinochoroiditis may be
more prevalent than is now recognized (23, 31, 32). Ocular
toxoplasmosis may be a component or the presenting manifes-
tation of human immunodeficiency virus infection or AIDS
(29). At present there is no consensus for the best initial
treatment for this eye disorder because of the poorly under-
stood pathogenesis (15, 32).
Fas (APO1/CD95) and its ligand (FasL, CD95 ligand) are
type I and type II transmembrane proteins and members of the
tumor necrosis factor/nerve growth factor receptor and tumor
necrosis factor families of proteins, respectively (5, 22, 37). Fas
is ubiquitously expressed on lymphoid and nonlymphoid cells,
while FasL is restricted to T cells and some nonlymphoid
tissues, known to be immune privileged sites, including the eye
(10, 24). The roles of these molecules in the regulation of
immunity and autoimmune disease have been extensively stud-
ied in lpr (for lymphoproliferation) and gld (for general lym-
phoproliferative disease) mice, which carry autosomal reces-
sive mutations and consequently lack functional expression of
Fas and FasL (24, 30). Fas and FasL interaction is closely
associated with immune privilege and probably provides a bar-
rier to prevent the interaction of Fas1 inflammatory cells and
pathogens from damaging tissues in privileged sites or tissues
(10, 24). Recent studies in a herpes simplex virus-induced
model of ocular inflammation demonstrated that the Fas-FasL
interaction protected the infected eye from the spread of dan-
gerous inflammatory responses (9). We therefore hypothesized
that Fas-FasL interaction, as a protective mechanism against
infection by the protozoan parasite T. gondii, may be involved
in pathophysiological process of the parasite-induced ocular
inflammation.
Mice have been shown to be suitable for studying the patho-
genesis of this infection (7). A novel murine model of acquired
ocular toxoplasmosis was recently developed in our laboratory
by intracameral inoculation of strain PLK tachyzoites (12). In
this study, we describe the involvement of Fas-FasL interaction
in the parasite-induced ocular inflammation in mice.
MATERIALS AND METHODS
Parasite. T. gondii PLK was used throughout these experiments. This clone of
Me49 was produced and is maintained in our laboratory by continuous passage
in human fibroblasts in Eagle’s minimum essential medium (MEM; Gibco Lab-
oratories, Grand Island, N.Y.) supplemented with 10% newborn calf serum plus
antibiotics. Parasites used in these studies were obtained from tissue culture in
human fibroblast cells at passage ,50. All parasite challenge experiments were
performed with tissue culture-derived tachyzoites at various inoculum levels.
Animals. Female C57BL/6 (B6), B6-lpr, and B6-gld mice, 6 to 8 weeks of age,
were obtained from Jackson Laboratory (Bar Harbor, Maine). For each strain,
10 of each group were used in each experiment. These mice were bred under
approved conditions in the Animal Research Facility at Dartmouth Medical
School. Control mice of the same parental lineage were age and sex matched.
Intraocular inoculation of parasites. The mice were intracamerally challenged
as previously described in a herpesvirus-induced model of ocular inflammation in
mice (12, 35). Mice were anesthetized intraperitoneally with 0.08 ml of a 1:1
mixture of ketamine hydrochloride (Mallinckrodt Veterinary, Inc., Mundelein,
Ill.) and xylazine (Phoenix Pharmaceutical, Inc., St. Joseph, Mo.) diluted 1:1 with
sterile water. Mice were then placed under the operating microscope, and ante-
rior chamber paracentesis was performed by puncturing the cornea midway
between the limbus and central cornea on the right eye, using a glass micropi-
pette. After leaking aqueous humor was blotted, 5 ml of parasite suspension
containing 5,000 tachyzoites in MEM was injected into the anterior chamber via
a 33-gauge needle attached to a 50-ml Hamilton syringe. In some experiments, 5
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ml of MEM was inoculated into the contralateral eye or into eyes of additional
mice to exclude injection trauma as a cause of inflammatory reaction.
Clinical observation. Eyes of all mice were examined under the operating
microscope every day following intracameral challenge with T. gondii for con-
junctival congestion, corneal edema, pupillary dilatation, iris vessel prominence,
anterior chamber clouding, cataract, retinal opacification, loss of red reflex, and
scleral reaction. Mice were also monitored for evidence of systemic infection
such as behavior, fur ruffling, and moribund status. The presence of inflamma-
tion was scored on a scale of 0 (normal) to 51 as follows: 11, apparent ciliary
congestion around the cornea; 21, intense ciliary congestion with slight cornea
edema and anterior chamber clouding; 31, obvious intraocular inflammatory
reaction such as iris vessel prominence, vitreous, and retinal opacification; 41,
endophthalmitis; 51, obvious ophthalmia with systemic symptoms and/or death
in addition to 41 ocular inflammation. The final score included findings from
histopathological observation.
Histopathology. At day 8 after parasite challenge, eyes were enucleated after
mice were sacrificed by CO2 inhalation and were preserved in 10% buffered
formalin. Fixed eyes were embedded in paraffin, serially sectioned at 5 mm, and
stained with hematoxylin and eosin. The pathological changes were scored on a
scale of 0 (normal) to 51, similar to the clinical scores: 0, normal histology; 11,
vessel dilation, protein precipitate, and ,20 inflammatory cells in anterior cham-
ber and vitreous humor per single section; 21, obvious inflammatory reaction
(more than 20 but fewer than 50 inflammatory cells in the ocular cavity) in the
anterior segment and few focal lesions of the inner retina; 31, .50 inflammatory
cells in the anterior chamber and vitreous humor, with moderate necrotic reti-
nitis, uveitis, keratitis, vitreitis, and cataract formation; 41, intensive retinouveitis
or endophthalmitis; 51, features of the preceding classes with extraocular in-
flammation including scleritis, conjunctivitis, and blepharitis.
Flow cytometry analysis for Fas and FasL on splenocytes. To evaluate the
influence of T. gondii on Fas and FasL expression, normal splenocytes were
isolated and incubated in vitro with T. gondii tachyzoites (splenocyte/parasite
ratio of 2:1) for 48 h. Fresh splenocytes of infected mice that had been inoculated
intraocularly with 5,000 tachyzoites were isolated from the spleens harvested at
day 8 postinfection. The splenocytes were stained with antibodies to CD95 (Jo2)
and to CD95L (Kay-10) (PharMingen, San Diego, Calif.) and analyzed by flow
cytometry as previously described (20). Normal splenocytes were stained as the
control, and the isotype antibodies hamster immunoglobulin G (IgG) and mouse
IgG2b were used for staining as controls to CD95 and CD95L, respectively.
Fas and FasL detection by immunohistostaining. The eyes were harvested at
day 8 from mice given 5,000 intraocular tachyzoites and were frozen immedi-
ately. Immunohistochemistry on frozen sections were carried out with monoclo-
nal antibodies to Fas (N-18) and to FasL (N-20) (Santa Cruz Biotechnology Inc.,
Santa Cruz, Calif.) as specified by the manufacturer. Briefly, the sections were
exposed at room temperature for 30 min and fixed in cold acetone. Endogenous
peroxidase activity was quenched in 0.8% hydrogen peroxide, and nonspecific
binding was blocked with 1.5% normal goat serum in phosphate-buffered saline
(PBS; pH 7.4). Sections were incubated with antibodies to either Fas or FasL at
room temperature for 30 min and then incubated with biotin-conjugated second
antibodies. After a series of three washes in PBS and a rinse in 1% Triton
X-100–PBS, the sections were incubated in diaminobenzidine solution for 2 min
for visible color and counterstained in hematoxylin for contrast.
Detection of apoptosis. By using a terminal deoxynucleotidyltransferase (TdT)
in situ apoptosis detection kit with TACS blue label (Genzyme Diagnostics,
Cambridge, Mass.), TdT-mediated dUTP-biotin nick end labeling (TUNEL) (2)
was applied to the paraffin-embedded sections of the injected eyes of B6 mice for
direct detection of apoptosis according to the manufacturer’s protocol. Briefly,
ocular tissues (harvested at 48 h, 96 h, and 8 days after intraocular infection) on
slides were deparaffinized at 57°C for 5 min on a slide warmer and then washed
three times, once each in 100, 95, and 70% ethanol. Samples were permeabilized
with proteinase K (1:50) for 5 min at room temperature, and endogenous per-
oxidase was quenched in a solution of 2% H2O2. TdT labeling was carried out
with the TdT enzyme (1:50) in 13 labeling buffer in the humidity chamber at
37°C for 1 h, followed by detection of TACS blue label for 6 min. After washing
with deionized water, counterstaining was performed with Red counterstain C
solution for 30 s. Normal B6 eyes were used as controls, and HL-60, ML-1, and
WI-L2 cell lines supplied by the manufacturer were used as positive and negative
controls of apoptosis.
Determination of CD81 and CD41 T cells in the eye. The frequency of CD81
and CD41 T cells in the eye at day 8 postinfection was determined by immuno-
phenotyping as described previously (38). Briefly, 30- to 70-mm sections of fresh
enucleated eye were cut with a vibratome (V1000; Technical Products Interna-
tional Inc., St. Louis, Mo.). Fluorescein isothiocyanate-conjugated antibodies
(L3T4 for CD4, Ly2 for CD8, and rat IgG2a k as controls; 2 mg/100 ml; PharM-
ingen) in PBS were added to sections, which were then incubated overnight at
4°C in the dark. Stained sections were visualized in a Bio-Rad MR1000 confocal
scanning laser microscope system equipped with a krypton-argon laser. Using
this system, we were able to optically section the specimens and build three-
dimensional reconstructions of the tissue sections. This allowed accurate deter-
mination of the specific relationships among cells. Using Image Space software
(Molecular Dynamics), we counted cell numbers in three dimensions (within an
area of 240.5 by 240.5 mm) and derived semiquantitative estimations of staining
intensities.
Statistical analysis. Clinical observation, pathological evaluation, and deter-
mination of T cells in the eyes by confocal scanning were carried out in a
double-blind manner by at least two investigators. Variations were expressed as
standard errors of the mean, and statistical comparisons between groups were
performed by Student’s t test. P values less than 0.05 were considered statistically
significant.
RESULTS
Ocular inflammatory reaction of wild-type B6 mice. All mice
receiving 5,000 parasites developed significant ocular inflam-
mation at day 6 or 7. Inflammation progressed with time as
described previously (12). The inflammation score was 3.3 6
0.7 (n 5 10 [Fig. 1 and 2]). Histopathologic analysis was con-
sistent with clinical observation. Intraocular inflammation was
FIG. 1. Clinical scores of different groups of mice inoculated with 5,000
strain PLK tachyzoites.
FIG. 2. Clinical score at day 8 of each group of mice inoculated with 5,000
strain PLK tachyzoites.
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obvious (Fig. 3B) and characterized as predominantly mono-
nuclear inflammatory infiltration, accompanied by necrotic ret-
initis or uveoretinitis.
Ocular inflammation in B6-lpr and B6-gld mice. Mice with
Fas or FasL mutations differed from the parental strain with
respect to the induction and severity of the inflammation. The
mutant mice were more susceptible than wild-type B6 mice to
the parasites. Both Fas and FasL mutant mice that received
5,000 parasites had increased local ocular inflammation, and
half exhibited ophthalmia. Obvious systemic reactions such as
fur ruffling and/or moribund status were observed in all mice at
day 8 postinoculation. The inflammation scores at day 8 after
inoculation were 4.1 6 0.4 (n 5 10) and 4.0 6 0.3 (n 5 10) for
the B6-lpr and B6-gld mice, respectively. The inflammatory
reaction was significantly more severe than that of the wild-
type B6 mice (P , 0.05). The inflammation was first noted at
day 4 or 5 in the injected eyes of B6-lpr or B6-gld mice (Fig. 1
and 2). Histopathologically, the inflammation was intense and
associated with tissue destruction. The cornea became thick-
ened, consisting of a large number of inflammatory cells and
neovascularization. The anterior chamber was filled with in-
flammatory cells and protein, accompanied by necrotic irido-
cyclitis and cataract formation in all mice. In the posterior
segment, necrotic retinitis and uveitis were seen, with striking
involvement of vitreous humor and sclera (Fig. 3C and D).
Increased expression of Fas and FasL in infected eyes and
splenocytes. Immunohistostaining showed that normal B6
mouse retina expressed Fas (Fig. 4A) as well as FasL (Fig. 4C),
which had been previously demonstrated in mice by Griffith et
al. (9, 10). The observation is consistent with the report that
Fas and FasL are expressed constitutively in normal human
retina (2). The inflamed parasite-inoculated eyes harvested at
day 8 postinfection showed a striking increase of both Fas (Fig.
4B) and FasL (Fig. 4D) expression.
Analysis by flow cytometry showed that T. gondii enhanced
expression of Fas and FasL on normal B6 mouse splenocytes
incubated with the PLK strain of the parasite (2:1) for 48 h
(Fig. 5a and b). Fas and FasL expression on splenocytes of B6
mice infected intraocularly with T. gondii PLK was also notably
increased (Fig. 5c and d).
Apoptosis in the eye. There was no evidence of apoptosis in
the normal control B6 eyes (Fig. 6A and B). Apoptosis of
infiltrating cells was observed in the anterior chamber 48 h
(Fig. 6C) and in the vitreous humor of the injected eyes of the
B6 mice 96 h (Fig. 6D) after intraocular infection. These ap-
optotic changes were demonstrated as well in ocular tissues
such as the lens (Fig. 6E) and retina (Fig. 6F), associated with
intraocular inflammation at day 8 after infection. In compari-
son to wild-type B6 mice, B6-lpr and B6-gld mice demonstrated
FIG. 3. (A) Uninfected eye; (B to D) ocular inflammation at day 8 of B6 mice (B) and significantly more intensively inflammatory reaction of the eyes of B6-lpr
(C) and B6-gld (D) mice intraocularly infected with 5,000 tachyzoites. (Magnification, 320.)
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much less apoptosis (Fig. 6G and H) of the infiltrating cells and
tissues of the T. gondii-infected eyes.
Frequency of CD81 and CD41 T cells in infected eyes. Both
CD81 (Fig. 7A) and CD41 (Fig. 7B) T cells were evident, with
a predominance of CD81 T cells in the infected eyes at day 8.
DISCUSSION
Ocular toxoplasmosis causes destructive intraocular inflam-
mation targeting the retina and uvea and potentially resulting
in blindness (15, 27, 32). Intracameral inoculation of tachy-
zoites of T. gondii PLK induced ocular inflammation, as we
have previously reported (12). Histopathologic analysis of the
ocular lesions demonstrated predominantly mononuclear cell
infiltration and tissue necrosis within the eye, which resembles
features of ocular toxoplasmosis in humans. Using this in vivo
model, we have demonstrated that Fas and FasL expression is
enhanced on splenocytes as well as in tissues of the eye, ac-
companied by apoptosis which occurred in early through late
stage in this study. Meanwhile, earlier and more severe intraoc-
ular inflammation was observed in both B6-lpr and B6-gld mice
that lack Fas or FasL compared to parental B6 mice. The
results indicate that the Fas-FasL system is involved in the
process of parasite-induced ocular inflammation and that ap-
optosis is associated with the inflammatory reaction in the eye.
FIG. 4. Fas (A) and FasL (C) expression on normal B6 mouse retina (arrows) and strikingly increased Fas (B) and FasL (D) expression on inflammatory retina
of the infected eye at day 8 after intraocular infection with 5,000 parasites. R, retina; U, uvea; V, vitreous humor. (Magnification, 3120.)
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The possibility that Fas-FasL interaction plays a role in pro-
tection of the eye was suggested by study of a murine model of
herpesvirus-induced ocular inflammation (9). Herpesvirus in-
duces uveoretinitis and keratitis which are mediated mainly by
CD41 T cells (16, 26). In our murine model, T. gondii-induced
host response and intraocular inflammation are mediated pre-
dominantly by CD81 T cells, as shown in this and a previous
(17) study. On the other hand, herpesvirus is a documented
inducer of apoptosis (34), while the role of T. gondii in the
apoptotic process remains unresolved (20, 21, 25). To clarify
the role of Fas-FasL in the process of ocular toxoplasmosis, we
have shown for the first time that enhanced Fas-FasL expres-
sion was indeed involved and apoptosis occurred in T. gondii-
infected eyes.
It is of interest that Fas and FasL expression is significantly
increased not only on host splenocytes incubated in vitro with
the parasite but also on splenocytes harvested from the in-
traocularly infected mice. The results are consistent with ob-
servations demonstrating induction of Fas on lymphocytes by
in vitro coculture with T. gondii tachyzoites (13). Further, Fas
and FasL were expressed in the normal mouse eyes, and the
level of expression was significantly enhanced upon parasite
infection. It is speculated that the increase in Fas and FasL
expression of the infected eye could be due directly to para-
sites, and the increased expression of the apoptotic marker in
splenocytes of the infected mice might be elicited directly by
the organisms that have migrated to the spleen from the inoc-
ulated eye. Details of the mechanisms by which the parasite
enhances the expression of Fas and FasL in the eye and how
the parasites inoculated in the eye influence the expression of
apoptotic molecules on the splenocytes remain to be eluci-
dated.
Our results suggest that a decrease in either Fas or FasL
expression may lead to rapid development of severe and de-
structive ocular inflammation. We hypothesize that apoptosis
induced by Fas-FasL interaction may play a role in protection
in the anterior chamber in early events after the inoculation of
parasites. It is suggested that mice with deficient Fas-FasL
function have a decreased capability to limit parasite replica-
tion so that inflammation is more intense and destructive than
in the parental mice with normal Fas-FasL expression.
Apoptosis is an important mechanism for protection against
virus infection in the eye (9, 33). The potential role of T. gondii
in apoptotic processes is not entirely understood. Protozoan
parasite activation-induced CD41 T-cell apoptosis has been dem-
onstrated during acute T. gondii infection in mice (20). Gamma
interferon-induced, Fas-dependent apoptosis of Peyer’s patch
T cells in mice follows peroral infection with T. gondii (21),
while T. gondii-infected cells demonstrate resistance to multi-
ple inducers of apoptosis (25). The present study of ocular toxo-
plasmosis is supportive of the notion that T. gondii can evoke
apoptosis. Apoptosis, in contrast to necrosis, characteristically
FIG. 5. Compared with the control isotype antibodies (light line), increased expression (bold line) of Fas and FasL on normal B6 mouse splenocytes incubated for
48 h with T. gondii PLK (2:1) (a and b) and on infected B6 mouse splenocytes and harvested at day 8 after intraocular inoculation with 5,000 tachyzoites (c and d).
FIG. 6. No apoptosis was detected in the anterior chamber and vitreous humor and in tissues such as the cornea, lens and retina of the eye (A and B). Apoptosis
(dark blue) of infiltrating cells was seen in the anterior chamber of B6 mice at 48 h (C) and in the vitreous humor at day 4 (D), and apoptotic cells in the lens (E) and
retina (F) were detected at day 8 after intraocular inoculation of 5,000 parasites. There were fewer apoptotic cells in the eyes of either B6-lpr (G) or B6-gld (H) mice
at day 4 after infection. Ac, anterior chamber; C, cornea; Cb, ciliary body; L, lens; R, retina; U, uvea; V, vitreous humor. (Magnification, 3200.)
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does not elicit an inflammatory response, thereby allowing an
organism to safely eliminate unnecessary or potentially harm-
ful cells (36). It seems, however, that enhanced Fas-FasL ex-
pression and possible Fas-FasL-induced apoptosis may play
dual roles during active toxoplasma replication in the eye. In
the early stage apoptosis may be protective, helping to elimi-
nate the relatively small number of tachyzoites. In contrast,
overproduction of Fas-FasL is invoked in the pathogenesis of
a number of diseases, such as hepatitis, thyroiditis, and uveitis
(2, 6). Apoptosis in the retina observed in the late stage of
ocular toxoplasmosis may be the result of increased expression
of Fas and FasL and may contribute to ocular tissue damage.
An imbalance between the protective and destructive effects
of the host immune response in the pathogenesis of ocular
toxoplasmosis has been suggested (3). The control of systemic
infection is dependent on a strong cell-mediated immune re-
sponse (4, 14). There is abundant evidence for the crucial role
of CD81 T cells in systemic immunity to this pathogen (4, 14,
19). CD41 T cells appear to synergize with CD81 T cells to
afford protection against T. gondii (8). Whether these T-cell
subsets act in the eye as they do in the systemic infection
remains to be illustrated. Further studies are under way to
identify in detail the mechanisms by which Fas and/or FasL
expression may interact with CD81 and/or CD41 T cells and
the phenotype of the apoptotic cells that we observed in ocular
tissues.
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